Pharmaceutical research and discovery from Pharma Journal: target identification, preclinical science, drug-development platforms and the laboratories advancing new therapies. The science and strategy behind the industry's pipeline, for professionals across biotech, pharma and academia.
Few words conjure discomfort quite like "faecal transplant". Yet in the halls of Britain's leading hospitals, this unlikely therapy is proving itself to be a quiet revolution in the battle against sup
By Dr. Eleanor Vance, Regulatory Affairs Editor
For millions of people around the world, living with HIV no longer means an automatic decline in health. Antiretroviral therapy, commonly referred to as ART, has transformed a once-fatal infection int
By Dr. Eleanor Vance, Regulatory Affairs Editor
We often attribute trust, affection, and intimacy to matters of the heart, but the chemistry of connection resides deeper, inside the brain. At the centre of this emotional circuitry lies oxytocin, a
By Dr. Eleanor Vance, Regulatory Affairs Editor
In the long and often punishing battle against cancer, modern medicine has relied heavily on eradication: cut, burn, poison — remove the disease before it removes the patient. While effective in many
By Dr. Eleanor Vance, Regulatory Affairs Editor
The genetic revolution has delivered extraordinary advances in how we understand, diagnose, and treat disease. With a simple saliva test, we can trace ancestry, assess inherited risk factors, or contr
By Dr. Eleanor Vance, Regulatory Affairs Editor
Non-alcoholic fatty liver disease (NAFLD) has evolved into one of the most pressing global health concerns of the 21st century. Closely linked to rising rates of obesity and type 2 diabetes, it affect
By Dr. Eleanor Vance, Regulatory Affairs Editor
In recent years, post-traumatic stress disorder (PTSD) has increasingly come under the spotlight as one of the most complex and stubborn mental health conditions confronting both clinicians and patien
By Dr. Eleanor Vance, Regulatory Affairs Editor
Chronic low back pain (cLBP), defined as pain persisting for over three months, is a widespread condition affecting millions globally. It is a leading cause of disability and places a significant stra
By Priya Raghavan, Biotech & Markets Analyst
Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. Affecting millions worldwide, it leads to intestinal damage, nutrient malabsorp
By Dr. Eleanor Vance, Regulatory Affairs Editor
Autoimmune diseases affect millions worldwide, with conditions like rheumatoid arthritis, lupus, and multiple sclerosis disrupting daily life for patients. These disorders occur when the body's immune
By Dr. Eleanor Vance, Regulatory Affairs Editor
For decades, aspirin has been the unsung hero of medicine cabinets across the world. From soothing headaches to reducing heart attack risks, it has earned its reputation as a household staple. However
By Priya Raghavan, Biotech & Markets Analyst
Understanding Congenital Blindness and Its Genetic Causes Congenital blindness is a condition where a child is born with severe visual impairment or complete blindness due to genetic mutations. One of
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy